| Authors: |
Kishimoto K; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan. ken@yacht.ocn.ne.jp.; Cancer Control Center, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-Ku, Osaka, 541-8567, Japan. ken@yacht.ocn.ne.jp., Hyodo S; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan., Fukushima K; Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Japan., Irie K; Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Japan., Horikawa S; Department of Pediatrics, Kagoshima University Hospital, Kagoshima, Japan., Uemura S; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan., Kozaki A; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan., Saito A; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan., Ishida T; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan., Mori T; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan., Hasegawa D; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan., Fukushima S; Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Japan., Kosaka Y; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan. |
